$ALDX
Aldeyra Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Concord, MA
ALDX chart
What traders are saying about $ALDX
Latest postsAldeyra Therapeutics, Inc. news
- Aldeyra Therapeutics Requests FDA Transfer Of ADX-2191 Ind Review For PVRL To Division Of Hematologic Malignancies 2 - SEC Filing
TradingView ·
- Weekly Recap: Reproxalap rejection appeal and cash runway into 2029
TradingView ·
- Aldeyra Therapeutics Inc (137.DU) Seasonal returns chart
Yahoo Finance UK ·
- Aldeyra Therapeutics Stock Price Forecast. Should You Buy ALDX?
StockInvest.us ·
- Aldeyra Therapeutics, Inc. (137.F) Analyst Insights, Price Targets & Recommendations - Yahoo Finance
Yahoo! Finance Canada ·
- Barclays reports a passive stake above 5% in Aldeyra Therapeutics (ALDX).
Stock Titan ·
- Aldeyra Therapeutics (ALDX) Stock Price, News & Analysis
Stock Titan ·
- Aldeyra Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Aldeyra Therapeutics 3Q 2026: EPS ($0.06) — 10-Q Summary
TradingView ·
- RARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a Week
Yahoo Finance ·
- Here's Why You Should Add ANRO Stock to Your Portfolio Now
Yahoo Finance ·
- Syndax Stock Falls 16% as Phase II Fibrosis Study Misses Primary Goal
Yahoo Finance ·
Aldeyra Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$33.8M | -$55.9M | -$37.5M | -$62.0M |
| Diluted EPS | $-0.56 | $-0.94 | $-0.64 | $-1.06 |
| Total assets (year end) | $72.1M | $104.6M | $148.3M | $181.3M |
| Cash and equivalents (year end) | $70.0M | $54.5M | – | $144.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aldeyra Therapeutics, Inc.
- Ticker
- ALDX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Concord, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1341235
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
Frequently asked questions
What exchange is Aldeyra Therapeutics, Inc. listed on?
Aldeyra Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ALDX.
What industry is Aldeyra Therapeutics, Inc. in?
Aldeyra Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aldeyra Therapeutics, Inc. headquartered?
Aldeyra Therapeutics, Inc.'s business address on file with the SEC is in Concord, MA.
When does Aldeyra Therapeutics, Inc.'s fiscal year end?
Aldeyra Therapeutics, Inc.'s fiscal year ends on December 31.